Avalo Therapeutics, Inc. Common Stock
$14.77
USD
Last updated on --.
24h volume1.12M
24h highest14.8200 USD
24h lowest13.9600 USD
24h Price movement+8.05%
AVTX recent prices
24 Hours
+8.05%+$1.100
30 days
-22.54%-$4.285
60 days
+5.94%+$0.825
90 days
-8.08%-$1.295
Key data
Previous close13.6700 USD
Market cap688.61M USD
Volume1.12M
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-1.6100 USD
Net income (FY)-84.74M USD
Revenue (FY)59.00K USD
Last report dateMay 13, 2026
About Avalo Therapeutics, Inc. Common Stock
HeadquartersWAYNE
Employees (FY)33.00
Revenue per employee (FY)1.79K USD
Net income per employee (FY)-2.57M USD
Listed onNasdaq
AVTX conversion tables
 |  |
|---|---|
| 0.5 AVTX | 7.385 USD |
| 1 AVTX | 14.77 USD |
| 5 AVTX | 73.85 USD |
| 10 AVTX | 147.7 USD |
| |
|---|---|
| 0.5 USD | 0.033852 AVTX |
| 1 USD | 0.067705 AVTX |
| 5 USD | 0.33852 AVTX |
| 10 USD | 0.67705 AVTX |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
AVTX is trading at $14.77, +8.05% over the last 24 hours. Track live moves on the price chart at the top of this page.
The AVTX stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. AVTX is currently trading at $14.77, +8.05% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on AVTX price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. AVTX's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from AVTX; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against AVTX's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
Avalo Therapeutics, Inc. Common Stock's market cap is currently 688.61M USD. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume1.12M
24h highest14.8200 USD
24h lowest13.9600 USD
24h Price movement+8.05%
Start trade with AVTX Perpetual
Sign up to trade